Philippine Customs Seize Over 2kg of Kush at Port

Jun.05.2024
Philippine Customs Seize Over 2kg of Kush at Port
Philippine Customs Bureau seized over 2kg of kush and 156 cannabis e-cigarettes worth $66,267 at Clark Port on June 5.

According to a report from the Philippine News Agency on June 5th, the Bureau of Customs (BOC) in the Port of Clark, Philippines, intercepted over 2 kilograms of kush (high-grade marijuana) and 156 disposable e-cigarettes containing marijuana, with an estimated value of over 3.9 million Philippine pesos ($66,267). The package was declared as "accessories" imported from California, USA.


On June 5th, the cargo was marked by X-ray Inspection Project (XIP) personnel due to abnormal X-ray images. Later, after being sniffed by a police dog, it was found to potentially contain illegal drugs. The Philippine Drug Enforcement Agency (PDEA) confirmed the presence of marijuana in the package after conducting chemical laboratory analysis.


The Customs Bureau has issued detention and arrest warrants for violations of sections 118 (g), 119 (d) and section 1113 paragraphs f, I, and l (3 and 4) of the Customs Modernization and Tariff Act, as well as the number 9165 law.


The Director General of the Philippines' Bureau of Customs stated:


The recent seizure operation has demonstrated the efforts we are making to combat drug trafficking and ensure community safety. We will continue to strengthen our operations, enhance our capabilities, and prevent any attempts to smuggle illegal substances into the country.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
According to IQOS Japan’s official website, the company has introduced three custom bundle sets for its IQOS ILUMA i lineup, combining devices with accessories as bundled offerings, and began rolling them out across multiple sales channels from Jan. 29.
Jan.29 by 2FIRSTS.ai
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%
Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.
Feb.09 by 2FIRSTS.ai
PMI U.S. to Host Job Fair for ZYN Nicotine Pouch Factory in Colorado
PMI U.S. to Host Job Fair for ZYN Nicotine Pouch Factory in Colorado
PMI U.S. plans to host a job fair to recruit employees for its ZYN nicotine pouch manufacturing facility currently under construction in Aurora, Colorado. The main position being recruited is Process Technician, responsible for equipment operation and maintenance, quality and safety monitoring, and supporting continuous production improvements.
Mar.12 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24